Introduction: A new stability-indicating liquid chromatographic method has been established for the determination of Fluorometholone. Fluorometholone is used for the treatment of eye diseases. Materials and Methods: The Shimadzu Model CBM-20A/20Alite high-performance liquid chromatography (HPLC) system was monitored at detection wavelength 241 nm on isocratic mode with flow rate 0.8 mL/min, and the total run time is 10 min. Chromatographic separation was achieved through Phenomenex Luna C 8 column (250 mm × 4.6 mm i.d., 5 µm particle size). The method was validated and stress degradation studies were conducted. Results and Discussion: Fluorometholone has obeyed Beer-Lambert's law over a concentration range 0.5-100 µg/ mL with linear regression equation, y = 70155x + 31667 and correlation coefficient of 0.9996. The limit of detection and limit of quantitation are found to be 0.1617 µg/mL and 0.4502 µg/mL, respectively, and the % RSD in precision, accuracy, and robustness studies was found to be less than 2%. Fluorometholone was found to be highly resistant toward all degradation conditions such as acidic, alkaline, thermal, and oxidation. Conclusions: It is concluded that the proposed reversed-phase HPLC method is accurate, precise, sensitive, and reproducible for the determination of Fluorometholone in pharmaceutical formulations, and the method was validated as per ICH guidelines.
INTRODUCTION

F luorometholone
[ Figure 1 ] is a corticosteroid used after laser-based refractive surgery. [1] Fluorometholone (FLM) is a glucocorticoid employed in the treatment of allergic and inflammatory conditions of the eye. It is available with brand names FLOSOFT (Cipla), flurisone (Label claim: 0.1% and 0.25%) (MicroVision), and FML (Allergan India Ltd) eye drops. Only one high-performance liquid chromatography (HPLC) method [2] is available in the literature and the authors have developed a stabilityindicating reversed-phase HPLC (RP-HPLC) method for the determination of FLM in the present study and the method was validated. [3] 
MATERIALS AND METHODS
Chemicals and reagents
Methanol, sodium hydroxide, hydrochloric acid, acetic acid, and hydrogen peroxide (H 2 O 2 ) were purchased from Merck RESEARCH ARTICLE (India) . All chemicals are of HPLC grade. All chemicals were of analytical grade and used as received.
Instrumentation and chromatographic conditions
Chromatographic separation was achieved using Shimadzu Model CBM-20A/20Alite HPLC system equipped with SPD-M20A prominence photodiode array detector with C 8 Phenomenex Luna column (250 mm × 4.6 mm i.d., 5 µm particle size) maintained at 25°C. Isocratic elution was performed using 0.1% acetic acid and methanol (20:80%, v/v) and the flow rate was 0.8 mL/min. The detection was carried at 241 nm. 20 µL of sample was injected into the HPLC system, and all chromatographic conditions were performed at room temperature (25°C±2°C). Stock solution of Fluorometholone (1000 µg/mL) was prepared with mobile phase, and further dilutions were made after filtering through 0.45 µm membrane filter.
Method validation
A series of solutions (0.5-100 µg/mL) were prepared from Fluorometholone stock solution, and 20 µL of each solution was injected into the HPLC system. The peak area of the chromatogram was noted, and calibration curve was plotted by taking the concentration of the solutions on the x-axis and the corresponding peak area values on the y-axis. The intraday precision and the interday precision studies were conducted at three concentration levels (10, 20, and 50 µg mL) on three different days, that is, day 1, day 2, and day 3, and the % RSD was calculated. The accuracy of the assay method was evaluated (80%, 100%, and 120%) using standard addition method and recovery experiments. The robustness of the assay method was established by introducing small changes in the HPLC conditions such as wavelength (239 and 243 nm), percentage of methanol in the mobile phase (78% and 82%), and flow rate (0.7 and 0.9 mL/min) with 10 µg mL of Fluorometholone. The limit of quantification and limit of detection were based on the standard deviation of the response and the slope of the constructed calibration curve (n = 3), as described in ICH guidelines Q2 (R1). [3] 
Stress degradation studies
Forced degradation studies were performed to evaluate the stability indicating properties and specificity of the method. [4] All solutions for stress studies were prepared at an initial concentration of 50 µg/mL of FLM and refluxed for 60 min at 80°C and then diluted with mobile phase.
Acidic degradation was performed by treating the drug solution (50 µg/mL) with 0.1 M HCl for 60 min in a thermostat maintained at 80°C. The stressed sample was cooled, neutralized with NaOH and then diluted with mobile phase as per the requirement. 20 µL of this solution was injected into the HPLC system. Alkaline degradation was performed by treating the drug solution (50 µg/mL) with 0.1 N sodium hydroxide for 60 min in a thermostat maintained at 80°C. The stressed sample was cooled, neutralized with HCl and then diluted with mobile phase as per the requirement, and 20 µL of the solution was injected into the HPLC system. Oxidation degradation was performed by treating the drug solution (50 µg/mL) with 30% H 2 O 2 for 60 min in a thermostat maintained at 80°C. The drug solution mixture was cooled and then diluted with mobile phase as per the requirement, and 20 µL of the solution was injected into the HPLC system.
Assay of Fluorometholone
The available marketed formulations were collected from the local pharmacy store and extracted with mobile phase for Fluorometholone. The contents of the volumetric flask were sonicated for 30 min, filtered and diluted with mobile phase as per the requirement. 20 µL of these solutions were injected into the system after filtering through 0.45 µm membrane and the peak area was recorded from the respective chromatogram.
RESULTS AND DISCUSSION
Method development and optimization
A simple stability indicating RP-HPLC method has been developed for the determination of Fluorometholone. During the optimization process the column, flow rate, mobile phase composition was selected based on the system suitability parameters. Enable C18 column has shown good number of theoretical plates [ Figure 2 ], but the peak is not sharp and symmetrical due to its tailing factor (>2), and therefore, Phenomenex Luna C 8 Column [ Figure 3 ] was tried where the system suitability parameters were within acceptable Table 1 ]. Then, the mobile phase composition [ Table 2 and Figure 4 ] and flow rates [ Table 3 and Figure 5 ] were monitored. Mobile phase containing 0.1% acetic acid: Methanol (20:80, v/v) with flow rate of 0.8 mL/min has shown a sharp peak at 5.158 min for Fluorometholone.
Method validation
Fluorometholone has shown linearity 0.5-100 µg/mL [ Table 4 ] with % RSD 0.18-0.93 and the chromatographic response was shown in Figure 6 . The linear regression equations were found to be y = 70155x + 31667 (R² = 0.9996). The % RSD in intraday and interday precision and accuracy were found to be 0.20-0.86, 0.66-0.82, and 0.30-0.81, respectively, with a percentage recovery 98.88-99.5 [ Table 5 ]. The % RSD value in robustness study was also found to be <2.0% (0.62-1.04) indicating that the method is robust [ Table 6 ].
Analysis of ophthalmic formulations
The proposed method was applied for the determination of FLM in marketed formulations[ Figure 7 ]. The % recovery was found to be 98.0-99.0 [ Table 7 ]. 
Stress degradation studies
The overlay typical chromatogram obtained following the assay of stressed samples was shown in Figure 8 . Very slight decomposition (<5%) was observed when FLM drug was exposed to alkaline, thermal, acidic, and oxidative degradations [ Table 8 ]. The 3D chromatograms were shown in Figure 9 . The system suitability parameters are within acceptable criteria.
CONCLUSION
The proposed stability-indicating liquid chromatographic method can be applied for the determination of Fluorometholone in eye drops, and the drug is highly resistant toward all degradations. 
